BackSanara MedTech Overview

Sanara MedTech Current Cash

Track Sanara MedTech's current cash ($15M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$15.42M
↓ 9.07% YoYΔ $-1.54M vs prior year quarter

Peer trimmed avg / median

Loading

Sanara MedTech Current Cash History

Loading

Sanara MedTech vs. peers: Current Cash Comparison

Loading

Sanara MedTech Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sanara MedTech (SMTI) FAQ

Sanara MedTech (SMTI) currently reports a current cash of $15M as of June 2026. That compares with $17M in the prior-year period — down 9.1% year over year. Use the charts on this page to explore Sanara MedTech's current cash history and peer comparisons.

Sanara MedTech's current cash decreased from $17M to $15M — a 9.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sanara MedTech reported $15M in current cash as of June 2026. That compares with $17M in the prior-year period — down 9.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sanara MedTech, and consider following SMTI for alerts when major investors trade the stock.

Sanara MedTech is classified in the Healthcare sector. On current cash, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SMTI with unrelated industries.